1 Study Coverage
    1.1 Microneedles for Trans & Intradermal Drug Delivery Product Introduction
    1.2 Market by Type
        1.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Solid Microneedles
        1.2.3 Hollow Microneedles
        1.2.4 Dissolvable Microneedles
    1.3 Market by Application
        1.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Drugs
        1.3.3 Vaccines
        1.3.4 Proteins
        1.3.5 Peptides
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Estimates and Forecasts 2017-2028
    2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Estimates and Forecasts 2017-2028
    2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region
        2.4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022)
        2.4.2 Global Sales Microneedles for Trans & Intradermal Drug Delivery by Region (2023-2028)
    2.5 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region
        2.5.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022)
        2.5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Manufacturers
        3.1.1 Global Top Microneedles for Trans & Intradermal Drug Delivery Manufacturers by Sales (2017-2022)
        3.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microneedles for Trans & Intradermal Drug Delivery in 2021
    3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturers
        3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturers (2017-2022)
        3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2021
    3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type
        4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Sales by Type (2017-2022)
        4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Sales by Type (2023-2028)
        4.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
    4.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type
        4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Revenue by Type (2017-2022)
        4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
    4.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type
        4.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2022)
        4.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application
        5.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Sales by Application (2017-2022)
        5.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Sales by Application (2023-2028)
        5.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
    5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application
        5.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Revenue by Application (2017-2022)
        5.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
    5.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application
        5.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2022)
        5.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
        6.1.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
        6.1.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
    6.2 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
        6.2.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
        6.2.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
    6.3 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
        6.3.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
        6.3.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
        7.1.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
        7.1.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
    7.2 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
        7.2.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
        7.2.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
    7.3 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
        7.3.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
        7.3.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
        8.1.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
        8.1.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
    8.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
        8.2.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
        8.2.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
    8.3 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Region
        8.3.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2028)
        8.3.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
        9.1.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
        9.1.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
    9.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
        9.2.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
        9.2.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
    9.3 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
        9.3.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
        9.3.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
        10.1.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
    10.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
        10.2.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
    10.3 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
        10.3.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Becton Dickinson
        11.1.1 Becton Dickinson Corporation Information
        11.1.2 Becton Dickinson Overview
        11.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Becton Dickinson Recent Developments
    11.2 Nanopass Technologies
        11.2.1 Nanopass Technologies Corporation Information
        11.2.2 Nanopass Technologies Overview
        11.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Nanopass Technologies Recent Developments
    11.3 Radius Health
        11.3.1 Radius Health Corporation Information
        11.3.2 Radius Health Overview
        11.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Radius Health Recent Developments
    11.4 Clearside Biomedical
        11.4.1 Clearside Biomedical Corporation Information
        11.4.2 Clearside Biomedical Overview
        11.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Clearside Biomedical Recent Developments
    11.5 Dr. Prausnitz Group
        11.5.1 Dr. Prausnitz Group Corporation Information
        11.5.2 Dr. Prausnitz Group Overview
        11.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Dr. Prausnitz Group Recent Developments
    11.6 Zosano Pharma
        11.6.1 Zosano Pharma Corporation Information
        11.6.2 Zosano Pharma Overview
        11.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Zosano Pharma Recent Developments
    11.7 Corium International
        11.7.1 Corium International Corporation Information
        11.7.2 Corium International Overview
        11.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Corium International Recent Developments
    11.8 Circassia
        11.8.1 Circassia Corporation Information
        11.8.2 Circassia Overview
        11.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Circassia Recent Developments
    11.9 Valeritas, Inc.
        11.9.1 Valeritas, Inc. Corporation Information
        11.9.2 Valeritas, Inc. Overview
        11.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Valeritas, Inc. Recent Developments
    11.10 BD Medical
        11.10.1 BD Medical Corporation Information
        11.10.2 BD Medical Overview
        11.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 BD Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Microneedles for Trans & Intradermal Drug Delivery Industry Chain Analysis
    12.2 Microneedles for Trans & Intradermal Drug Delivery Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Microneedles for Trans & Intradermal Drug Delivery Production Mode & Process
    12.4 Microneedles for Trans & Intradermal Drug Delivery Sales and Marketing
        12.4.1 Microneedles for Trans & Intradermal Drug Delivery Sales Channels
        12.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
    12.5 Microneedles for Trans & Intradermal Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Microneedles for Trans & Intradermal Drug Delivery Industry Trends
    13.2 Microneedles for Trans & Intradermal Drug Delivery Market Drivers
    13.3 Microneedles for Trans & Intradermal Drug Delivery Market Challenges
    13.4 Microneedles for Trans & Intradermal Drug Delivery Market Restraints
14 Key Findings in The Global Microneedles for Trans & Intradermal Drug Delivery Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Solid Microneedles
    Table 3. Major Manufacturers of Hollow Microneedles
    Table 4. Major Manufacturers of Dissolvable Microneedles
    Table 5. Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
    Table 8. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2022)
    Table 9. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2023-2028) & (K Units)
    Table 10. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2023-2028)
    Table 11. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2017-2022)
    Table 13. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2023-2028)
    Table 15. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Manufacturers (2017-2022)
    Table 17. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Manufacturers (2017-2022)
    Table 19. Microneedles for Trans & Intradermal Drug Delivery Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Microneedles for Trans & Intradermal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedles for Trans & Intradermal Drug Delivery as of 2021)
    Table 22. Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Offered
    Table 24. Date of Manufacturers Enter into Microneedles for Trans & Intradermal Drug Delivery Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 27. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 28. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Type (2017-2022)
    Table 29. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Type (2023-2028)
    Table 30. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Type (2017-2022)
    Table 33. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Type (2023-2028)
    Table 34. Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 37. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 38. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Application (2017-2022)
    Table 39. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Application (2023-2028)
    Table 40. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Application (2017-2022)
    Table 43. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Application (2023-2028)
    Table 44. Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 47. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 48. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 51. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 52. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 55. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 56. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Becton Dickinson Corporation Information
    Table 107. Becton Dickinson Description and Major Businesses
    Table 108. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Becton Dickinson Recent Developments
    Table 111. Nanopass Technologies Corporation Information
    Table 112. Nanopass Technologies Description and Major Businesses
    Table 113. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Nanopass Technologies Recent Developments
    Table 116. Radius Health Corporation Information
    Table 117. Radius Health Description and Major Businesses
    Table 118. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Radius Health Recent Developments
    Table 121. Clearside Biomedical Corporation Information
    Table 122. Clearside Biomedical Description and Major Businesses
    Table 123. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Clearside Biomedical Recent Developments
    Table 126. Dr. Prausnitz Group Corporation Information
    Table 127. Dr. Prausnitz Group Description and Major Businesses
    Table 128. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Dr. Prausnitz Group Recent Developments
    Table 131. Zosano Pharma Corporation Information
    Table 132. Zosano Pharma Description and Major Businesses
    Table 133. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Zosano Pharma Recent Developments
    Table 136. Corium International Corporation Information
    Table 137. Corium International Description and Major Businesses
    Table 138. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Corium International Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Corium International Recent Developments
    Table 141. Circassia Corporation Information
    Table 142. Circassia Description and Major Businesses
    Table 143. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Circassia Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Circassia Recent Developments
    Table 146. Valeritas, Inc. Corporation Information
    Table 147. Valeritas, Inc. Description and Major Businesses
    Table 148. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Valeritas, Inc. Recent Developments
    Table 151. BD Medical Corporation Information
    Table 152. BD Medical Description and Major Businesses
    Table 153. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. BD Medical Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Microneedles for Trans & Intradermal Drug Delivery Distributors List
    Table 159. Microneedles for Trans & Intradermal Drug Delivery Customers List
    Table 160. Microneedles for Trans & Intradermal Drug Delivery Market Trends
    Table 161. Microneedles for Trans & Intradermal Drug Delivery Market Drivers
    Table 162. Microneedles for Trans & Intradermal Drug Delivery Market Challenges
    Table 163. Microneedles for Trans & Intradermal Drug Delivery Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Microneedles for Trans & Intradermal Drug Delivery Product Picture
    Figure 3. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Type in 2021 & 2028
    Figure 3. Solid Microneedles Product Picture
    Figure 4. Hollow Microneedles Product Picture
    Figure 5. Dissolvable Microneedles Product Picture
    Figure 6. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Application in 2021 & 2028
    Figure 7. Drugs
    Figure 8. Vaccines
    Figure 9. Proteins
    Figure 10. Peptides
    Figure 11. Others
    Figure 12. Microneedles for Trans & Intradermal Drug Delivery Report Years Considered
    Figure 13. Global Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2028 (K Units)
    Figure 14. Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Microneedles for Trans & Intradermal Drug Delivery Revenue 2017-2028 (US$ Million)
    Figure 16. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2022)
    Figure 18. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2023-2028)
    Figure 19. North America Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Microneedles for Trans & Intradermal Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Microneedles for Trans & Intradermal Drug Delivery in the World: Market Share by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2021
    Figure 31. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 33. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 34. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 35. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 36. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 37. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 38. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 39. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 40. North America Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 41. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 42. U.S. Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 45. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 47. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 49. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 50. Germany Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 51. France Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Region (2017-2028)
    Figure 61. China Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 64. India Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 76. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 77. Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 86. Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 89. Microneedles for Trans & Intradermal Drug Delivery Value Chain
    Figure 90. Microneedles for Trans & Intradermal Drug Delivery Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed